The new presentation sounded great to me. A lot of big things happening soon. In addition to the business related expectations, the uplisting also is good news. Even if a reverse split is required, it's just a formality, as long as no there's no new shares issued to accompany it. Reverse splits have a bad rep because they are often used to prevent delisting, when a stock is in trouble. When a stock uses the reverse split to get listed, it's another matter.
Sounds obvious to me. " IntelGenx is entitled to a one-time milestone payment of $3 million, of which $1 million will be payable 14 days after the milestone has been achieved, and the balance of $2 million payable six months later." How can they book it before it's paid?
igxtgold, you are wrong about a lot. First, let me say I am long IGXT. There are 71 million fully diluted shares. Annual expenses are about $3 million. They are taking out a loan for about $3 million for equipment, to be paid in 5 years. So they need income of $3.6 million, approx., per year, to break even. To have 10c EPS, they need something like $10 million in revenue next year. Milestones contribute to the earnings. It would be great to see migraine start to contribute, however Apotex is still having issues with the FDA. The sooner a second drug gets to the market, the sooner IGXT will really start to rise, in my opinion, for what that's worth. The milestones will also be positive news. Again in my opinion, for what that's worth. Yahoo list 2 analysts, with a consensus EPS for next year, you can look it up easily. They may be right, they may not.